Assam Reporter

Cystinuria Market to Exhibit Moderate Growth Rate till 2030, Investigates DelveInsight | Key Companies – Advicenne, Revive Therapeutics, Bausch, Otsuka Pharma, Retrophin, and Others

 Breaking News
  • No posts were found

Cystinuria Market to Exhibit Moderate Growth Rate till 2030, Investigates DelveInsight | Key Companies – Advicenne, Revive Therapeutics, Bausch, Otsuka Pharma, Retrophin, and Others

December 20
18:42 2021
Cystinuria Market to Exhibit Moderate Growth Rate till 2030, Investigates DelveInsight | Key Companies - Advicenne, Revive Therapeutics, Bausch, Otsuka Pharma, Retrophin, and Others
Delveinsight Business Research LLP
DelveInsight’s “Cystinuria Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Cystinuria Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Cystinuria market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Cystinuria Market

Cystinuria:An Overview

Cystinuria is an autosomal recessive disorder of renal tubular and intestinal transport of dibasic amino acids, resulting in increased urinary excretion of cystine, and dibasic amino acids ornithine, lysine, and arginine (COLA). However, in this disease, some heterozygote carriers have an autosomal dominant inheritance with incomplete penetrance.

Current pharmacological or interventional treatment of patients with cystinuria, while often effective in relieving or preventing symptoms, does not target either the underlying genetic defect or the key intermediary pathways involved in the pathogenesis of the phenotype. Moreover, the prevalence of diseases has steadily increased in the past few decades due to changes in diet and lifestyle, increasing the prevalence of obesity and diabetes, and migration from rural to urban areas.

Also, with higher temperatures resulting in dehydration and high urinary concentration of calcium and other stone-forming salts, global warming is a major contributor to the rise in prevalence. This leads to the high demand for effective therapies to treat cystinuria.

Cystinuria Market Key Facts

  • As per DelveInsight estimates, the total cases of Cystinuria in the 7MM were found to be 87,311 in 2020. Among all the countries, the estimates show a population of Cystinuria in the United States to be 33,265 in 2020.

  • Among the EU5 countries, Germany had the highest prevalent population of Cystinuria followed by France. On the other hand, Spain had the lowest prevalent population.

  • Cystinuria is found to be more prevalent in females as compared to males. In 2020, there were 17,764 prevalent cases of Cystinuria in females and 15,502 prevalent cases in males in the United States and as per DelveInsight’s analysts’ assessments, in both the genders same trend is seen in all the countries of 7MM.

  • In 2020, the diagnosed population of Cystinuria in the United States was found to be 23,755.  Among the European countries, Germany had the highest prevalent population of Cystinuria with 11,895 cases, followed by France. On the other hand, Spain had the lowest prevalent population in 2020.

Cystinuria Market 

Cystinuria Market size is expected to increase during the forecast period owing to the launch of emerging therapies

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Cystinuria market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Cystinuria market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Get the PDF Sample of the Report:- Cystinuria Therapeutics Market

Cystinuria Epidemiology

The epidemiology section covers insights about the historical and current Cystinuria patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Cystinuria Epidemiology Subtype Segmentation

  • Total Prevalent Cases of Cystinuria

  • Gender-specific Cases of Cystinuria 

  • Type- Specific Cases of Cystinuria 

  • Age-specific Cases of Cystinuria 

  • Diagnosed Cases of Cystinuria

Cystinuria Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cystinuria market or expected to get launched in the market during the study period. The analysis covers Cystinuria market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Cystinuria Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Cystinuria Therapeutics Analysis

Some of the key companies in the Cystinuria Market include:

  • Advicenne

  • Revive Therapeutics

  • Bausch Health

  • Mission Pharmacal/Retrophin

  • Otsuka Pharmaceutical

And several others

Cystinuria Therapies covered in the report includes:

  • ADV7103 

  • Bucillamine 

  • Cuprimine (d-penicillamine)

  • Tiopronin (Thiola)

  • Tolvaptan

And many more

Get More Detailed Insights into the Emerging Therapies & Key Companies:-

Table of Content

1. Key Insights

2. Executive Summary 

3. Cystinuria Competitive Intelligence Analysis

4. Cystinuria Market Overview at a Glance

5. Cystinuria Disease Background and Overview

6. Cystinuria Patient Journey

7. Cystinuria Epidemiology and Patient Population

8. Cystinuria Treatment Algorithm, Current Treatment, and Medical Practices

9. Cystinuria Unmet Needs

10. Key Endpoints of Cystinuria Treatment

11. Cystinuria Marketed Products

12. Cystinuria Emerging Therapies

13. Cystinuria Seven Major Market Analysis

14. Attribute Analysis

15. Cystinuria Market Outlook (7 major markets)

16. Cystinuria Access and Reimbursement Overview

17. KOL Views on the Cystinuria Market.

18. Cystinuria Market Drivers

19. Cystinuria Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample Report here:-

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States

Related Articles